Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Japanese Journal of Clinical Oncology|April 15, 2021
Histopathological atlas of desmoplastic reaction characterization in colorectal cancerHideki Ueno, Yoshiki Kajiwara, Yoich Ajioka, et al.
The Journal of Dermatology|March 8, 2021
Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trialKeita Tsutsui, Katsuko Kikuchi, Keiko Nozawa, et al.
Cancer Medicine|September 29, 2021
Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor-node-metastasis classification of colorectal cancer and the 9th edition of the Japanese classificationDai Shida, Narikazu Boku, Yuya Nakamura, et al.
Cancer Medicine|June 20, 2024
Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real-world analysisToru Kadono, Satoru Iwasa, Toshiharu Hirose, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 17, 2011
First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancerSatoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, et al.
International Journal of Clinical Oncology|October 16, 2010
Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective studySatoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, et al.
American Journal of Cancer Research|April 9, 2024
CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancerKotoe Oshima, Hirokazu Shoji, Narikazu Boku, et al.
BMC Cancer|March 29, 2018
Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in JapanDai Shida, Yuka Ahiko, Taro Tanabe, et al.
Anticancer Research|January 30, 2026
Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With NivolumabTakahito Awatsu, Toru Kadono, Hirokazu Shoji, et al.
CNS Oncology|June 13, 2024
<i>BRAF</i> V600E-mutant colorectal cancer with CNS metastases treated successfully with encorafenib, binimetinib and cetuximabToru Imai, Hirokazu Shoji, Hidekazu Hirano, et al.
Pageof 19